Yersinia pseudotuberculosis effector YopJ subverts the Nod2/RICK/TAK1 pathway and activates caspase-1 to induce...

Area of Science:

• Microbiology
• Immunology
• Cell Biology

Background:

• Yersinia pseudotuberculosis is an enteropathogenic bacterium that invades the host via the gut.
• The innate immune receptor Nod2 plays a role in intestinal immunity.
• Bacterial effectors can subvert host signaling pathways to promote infection.

Purpose of the Study:

• To investigate how Yersinia pseudotuberculosis effector YopJ disrupts the intestinal barrier.
• To elucidate the role of Nod2 signaling in YopJ-induced intestinal barrier dysfunction.
• To identify therapeutic targets for Yersinia infections.

Main Methods:

• Investigated YopJ's effect on intestinal barrier function in vitro and in vivo.
• Utilized Nod2-deficient cell lines and animal models.
• Performed biochemical assays to analyze YopJ's interaction with Nod2 signaling components.
• Measured cytokine levels, including IL-1β, and bacterial dissemination.

Main Results:

• YopJ induces intestinal barrier dysfunction by targeting Nod2 signaling.
• YopJ acetylates RICK and TAK1 kinases, central to Nod2 signaling.
• Nod2 activation by YopJ leads to caspase-1 activation and IL-1β production.
• IL-1β in Peyer's patches is crucial for YopJ-mediated barrier dysfunction.
• Pretreatment with muramyl-dipeptide reverses YopJ-induced barrier dysfunction.

Conclusions:

• Yersinia pseudotuberculosis effector YopJ exploits Nod2 signaling and the mucosal inflammatory response to disrupt the intestinal barrier.
• Targeting Nod2 signaling or IL-1β may offer therapeutic strategies against Yersinia infections.
• Understanding bacterial effector mechanisms is key to controlling enteric infections.